Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight. … [+4382 chars]Read More
Eli Lillys nextgeneration obesity drug retatrutide clears first latestage diabetes trial CNBC
